| Jose M Monroy Trujillo, MD | |
|
503 Byrn St, Cambridge, MD 21613-1917 | |
| (410) 221-7770 | |
| (410) 221-7863 |
| Full Name | Jose M Monroy Trujillo |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 20 Years |
| Location | 503 Byrn St, Cambridge, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740471861 | NPI | - | NPPES |
| 447103200 | Medicaid | MD | |
| E6360019 | Other | MD | BS FEDERAL |
| P20146 | Other | MD | BS POINT OF SERVICE |
| 97696702 | Other | MD | BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | D0073394 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Kidney Care Caroline Street | Baltimore, MD | Dialysis facility |
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
School and family influences on physical activity may be stronger in boys than in girls in Australia, according to a study published March 9, 2016 in the open-access journal PLOS ONE by Rohan Telford from the University of Canberra, Australia, and colleagues.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.
Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.
› Verified 5 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
School and family influences on physical activity may be stronger in boys than in girls in Australia, according to a study published March 9, 2016 in the open-access journal PLOS ONE by Rohan Telford from the University of Canberra, Australia, and colleagues.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.
Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.
› Verified 5 days ago
| Entity Name | M.s. Shariff, M.d., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073621975 PECOS PAC ID: 4284673567 Enrollment ID: O20050426001308 |
News Archive
School and family influences on physical activity may be stronger in boys than in girls in Australia, according to a study published March 9, 2016 in the open-access journal PLOS ONE by Rohan Telford from the University of Canberra, Australia, and colleagues.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.
Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.
› Verified 5 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902332133 PECOS PAC ID: 4981745098 Enrollment ID: O20170818000085 |
News Archive
School and family influences on physical activity may be stronger in boys than in girls in Australia, according to a study published March 9, 2016 in the open-access journal PLOS ONE by Rohan Telford from the University of Canberra, Australia, and colleagues.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.
Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose M Monroy Trujillo, MD 503 Byrn St, Cambridge, MD 21613-1917 Ph: (410) 221-7770 | Jose M Monroy Trujillo, MD 503 Byrn St, Cambridge, MD 21613-1917 Ph: (410) 221-7770 |
News Archive
School and family influences on physical activity may be stronger in boys than in girls in Australia, according to a study published March 9, 2016 in the open-access journal PLOS ONE by Rohan Telford from the University of Canberra, Australia, and colleagues.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
Patients who received telephone-delivered collaborative care for treatment of depression after coronary artery bypass graft surgery reported greater improvement in measures of quality of life, physical functioning and mood than patients who received usual care, according to a study in the November 18 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference.
Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.
Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.
› Verified 5 days ago
Mahmood S Shariff, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 105 Aurora St, Cambridge, MD 21613 Phone: 410-228-9515 Fax: 410-228-1453 | |
Mohamed Abdelbagi Omer Mohamed Ahmed, MD Nephrology Medicare: Medicare Enrolled Practice Location: 713 Cambridge Marketplace Blvd Ste 2-700, Cambridge, MD 21613 Phone: 410-820-4888 | |
Dr. Elena Tilly, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Byrn St, Dorchester General Hospital, Cambridge, MD 21613 Phone: 410-228-5511 Fax: 410-221-8783 | |
Dr. Farah Alli, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 505 Byrn St, Cambridge, MD 21613 Phone: 410-221-7770 Fax: 410-221-7863 | |
Dr. Encarnita Ignacio Santos-tecson, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 830 Chesapeake Dr, Cambridge, MD 21613 Phone: 410-901-4000 Fax: 410-901-4011 | |
Mahbuba Akhter, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 503 Byrn St Ste 2, Cambridge, MD 21613 Phone: 410-221-7770 Fax: 410-221-7863 | |
Annabelle B Talusan, MD Nephrology Medicare: Medicare Enrolled Practice Location: 830 Chesapeake Dr, Cambridge, MD 21613 Phone: 410-901-4000 Fax: 410-901-4011 |